Skip to content

To compare two local anesthetics with opioid and without opioid in spinal anesthesia for lower abdominal and lower extremity surgeries

A comparative study of hyperbaric levobupivacaine 0.5 percentage alone vs hyperbaric levobupivacaine 0.5 percentage with fentanyl in spinal anesthesia for lower abdominal and lower extremity surgeries - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075044
Enrollment
100
Registered
2024-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: Hyperbaric Levobupivacaine 0.5%: Hyperbaric Levobupivacaine 0.5% alone in 1st group who are undergoing Lower Abdominal and Lower Extremities Surgeries Control Intervention1: Hyperbaric

Sponsors

Dr Shantanu Yadav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 to 65 years scheduled for elective lower abdominal or lower extremity surgeries 2.American Society of Anaesthesiologists (ASA) physical status I or II

Exclusion criteria

Exclusion criteria: 1.Hypersensitivity to Local Anaesthetics or Opioids 2.Cardiac dysfunction 3.Respiratory Disease 4.Coagulation Disorders 5.Pregnancy 6.Inability to Provide Informed Consent 7.ASA Physical Status III or higher

Design outcomes

Primary

MeasureTime frame
Hyperbaric Levoupivacaine 0.5% with Fentanyl in Spinal Anesthesia for Lower Abdominal & Lower Extremity Surgeries found to have longer duration of sensory and motor blockage then hyperbaric levobupivacaine 0.5% aloneTimepoint: Primary outcome assessed in 5 minutes

Secondary

MeasureTime frame
Quality of subarachnoid block, hemodynamic stability, perioperative analgesia in patients undergoing for Lower Abdominal & Lower Extremity Surgeries are better in patients receiving levobupivacine 0.5% with fentanyl as compared to patients receiving levobupivacine 0.5% aloneTimepoint: secondary outcome assessed in 1 hour

Countries

India

Contacts

Public ContactDr Shivam Jaisawal

Varun Arjun Medical College and Rohilkhand Hospital

vkbhaskar@gmail.com9837027227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026